Know Cancer

or
forgot password

Population Based Pharmacokinetic and Pharmacodynamic Dosage Model for Cytarabine, Daunorubicin and Etoposide for Acute Myeloid Leukemia


N/A
18 Years
N/A
Not Enrolling
Both
Acute Myeloid Leukemia

Thank you

Trial Information

Population Based Pharmacokinetic and Pharmacodynamic Dosage Model for Cytarabine, Daunorubicin and Etoposide for Acute Myeloid Leukemia


Inclusion Criteria:



- adult men and women with newly diagnosed acute myeloid leukemia

Exclusion Criteria:

- under age 18 years

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

significant covariates from the PK study

Outcome Time Frame:

after complete analysis of data

Safety Issue:

No

Principal Investigator

Ove J Nielsen, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Rigshospitalet, Denmark

Authority:

Denmark: Danish Dataprotection Agency

Study ID:

AMLPKPD-20081127

NCT ID:

NCT00969891

Start Date:

September 2009

Completion Date:

August 2011

Related Keywords:

  • Acute Myeloid Leukemia
  • Leukemia
  • Leukemia, Myeloid, Acute
  • Leukemia, Myeloid

Name

Location